◼ Archived
Business
Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has finalized a $40 billion acquisition of Tylenol maker Kenvue, restructuring the global consumer health and wellness landscape.